MENU
+Compare
POAI
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.45
Change
-$0.02 (-1.36%)
Capitalization
9.22M

POAI Predictive Oncology Forecast, Technical & Fundamental Analysis

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.

POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for POAI with price predictions
Feb 21, 2025

POAI's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for POAI moved into oversold territory on February 21, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for POAI moved above the 200-day moving average on February 06, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where POAI advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for POAI moved out of overbought territory on February 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on POAI as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for POAI turned negative on February 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

POAI broke above its upper Bollinger Band on February 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. POAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.792) is normal, around the industry mean (23.499). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.955) is also within normal values, averaging (41.339).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2915 Commers Drive
Phone
+1 651 389-4800
Employees
34
Web
https://www.predictive-oncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL245.55-0.28
-0.11%
Apple
BTC.X96258.000000-319.757800
-0.33%
Bitcoin cryptocurrency
SPY599.94-10.44
-1.71%
SPDR® S&P 500® ETF Trust
GME26.42-0.62
-2.29%
GameStop Corp
TSLA337.80-16.60
-4.68%
Tesla

POAI and Stocks

Correlation & Price change

A.I.dvisor tells us that POAI and MBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POAI and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POAI
1D Price
Change %
POAI100%
+20.37%
MBOT - POAI
31%
Poorly correlated
-3.52%
SINT - POAI
30%
Poorly correlated
-4.41%
APDN - POAI
28%
Poorly correlated
-1.53%
DHAI - POAI
26%
Poorly correlated
-1.86%
PLSE - POAI
24%
Poorly correlated
+4.29%
More